Axogen

Axogen

Health Care Equipment & Supplies
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

$3.4B

Market Cap • 11/19/2026

1977

(49 years)

Founded

1986

(40 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

6,8

P/S

12,6

P/EBITDA

—

P/OCF

118,7

P/FCF

152,7

P/E

—

BVPS

8,3

EPS

—

Market Cap

Market Cap

3,4B

EV

3B

EV/Revenue

11,4

EV/EBITDA

-687,5

EV/EBIT

-220

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-11,2%

Total Yield

-11,2%

Payout

0%

Retained Earnings

-325,7M

Profitability

Gross Margin

74,2%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

14%

Capex/Revenue

2,4%

Capex/D&A

67,3%

Capex/OCF

22,3%

SBC/OCF

144,6%

% PPE

17,3%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

15,8%

CAGR Op. Income 5Y

-11,5%

CAGR Net Income 5Y

2,9%

CAGR EPS 5Y

-0,6%

Leverage

N.D./EBITDA

74,4

Debt/Equity

0%

Current Ratio

12

Quick Ratio

10,5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium